MoneyWorks4Me

Glenmark Pharmaceuticals submits Press Release

27 Nov 2024 Evaluate

Glenmark Pharmaceuticals has submitted Press Release that Glenmark Pharmaceuticals Inc., USA launches Travoprost Ophthalmic Solution USP, 0.004% (Ionic Buffered Solution).

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..